EPIS B Stock Overview A medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. More details
Rewards Risk Analysis + 2 more risks
See All Risk Checks Capture your thoughts, links and company narrative
Episurf Medical AB (publ) Competitors Price History & Performance
Summary of share price highs, lows and changes for Episurf Medical Historical stock prices Current Share Price SEK 0.11 52 Week High SEK 0.94 52 Week Low SEK 0.10 Beta 1.09 1 Month Change -9.49% 3 Month Change -26.24% 1 Year Change -88.09% 3 Year Change -96.57% 5 Year Change -92.26% Change since IPO -99.62%
Recent News & Updates
Consensus EPS estimates increase from loss to kr0.00 profit Feb 12
Full year 2024 earnings: EPS and revenues miss analyst expectations Feb 06
Episurf Medical Announces Update on the Episurf MTP Implant - Response to FDA Submitted Jan 30
Independent Chairman of the Board recently bought kr184k worth of stock Nov 08
Consensus revenue estimates increase by 850%, EPS downgraded Nov 01
Episurf Medical AB (publ) to Report Fiscal Year 2024 Results on Mar 06, 2025 Oct 29 See more updates
Consensus EPS estimates increase from loss to kr0.00 profit Feb 12
Full year 2024 earnings: EPS and revenues miss analyst expectations Feb 06
Episurf Medical Announces Update on the Episurf MTP Implant - Response to FDA Submitted Jan 30
Independent Chairman of the Board recently bought kr184k worth of stock Nov 08
Consensus revenue estimates increase by 850%, EPS downgraded Nov 01
Episurf Medical AB (publ) to Report Fiscal Year 2024 Results on Mar 06, 2025 Oct 29
Third quarter 2024 earnings released: kr0.024 loss per share (vs kr0.078 loss in 3Q 2023) Oct 25 Episurf Medical AB (publ) to Report Q2, 2025 Results on Jul 11, 2025
Chief Executive Officer recently bought kr2.3m worth of stock Sep 26
New major risk - Market cap size Sep 25
Consensus revenue estimates decrease by 22%, EPS upgraded Jul 19
Second quarter 2024 earnings released: kr0.03 loss per share (vs kr0.11 loss in 2Q 2023) Jul 14
New major risk - Shareholder dilution Jun 25 Episurf Medical AB (publ) has completed a Composite Units Offering in the amount of SEK 90.158983 million. Jun 14
Independent Director recently bought kr129k worth of stock Jun 13
Insufficient new directors Jun 02
Consensus EPS estimates fall by 14% Apr 25
First quarter 2024 earnings released: kr0.077 loss per share (vs kr0.087 loss in 1Q 2023) Apr 24
New major risk - Market cap size Apr 22
Shareholders May Be More Conservative With Episurf Medical AB (publ)'s (STO:EPIS B) CEO Compensation For Now Apr 03
Full year 2023 earnings: EPS and revenues miss analyst expectations Mar 12
Here's Why Episurf Medical (STO:EPIS B) Must Use Its Cash Wisely Feb 27
Full year 2023 earnings: EPS and revenues miss analyst expectations Feb 11
New major risk - Revenue and earnings growth Feb 09
New minor risk - Share price stability Feb 02
Episurf Medical AB (Publ) Receives Four Additional Patent Approval Notification Nov 29
Is Episurf Medical (STO:EPIS B) In A Good Position To Invest In Growth? Nov 09
Consensus revenue estimates decrease by 19% Nov 03
Price target decreased by 27% to kr4.00 Nov 01
Third quarter 2023 earnings released Oct 29 Episurf Medical AB (publ), Annual General Meeting, Apr 09, 2024
Episurf Medical Announces 510(k) Submission for Big Toe Implant Oct 20
Episurf Members Announces Nomination Committee for Episurf Medical's Annual General Meeting in 2024 Oct 17
Episurf Medical Announces Early Clinical Results from Episealer Talus Study Presented at Scientific Congress Sep 28
Episurf Medical Announces Prospective Episealer Talus Clinical Study Sep 14
Episurf Medical AB (publ) Announces First Commercial Case in the US Has Been Scheduled for Surgery Aug 23
Second quarter 2023 earnings released Jul 14
Chief Executive Officer recently bought kr660k worth of stock May 10
Will Episurf Medical (STO:EPIS B) Spend Its Cash Wisely? May 03
First quarter 2023 earnings released May 01
Chief Executive Officer recently bought kr72k worth of stock Feb 22
Full year 2022 earnings: EPS and revenues miss analyst expectations Feb 19
Episurf Medical AB (publ), Annual General Meeting, May 04, 2023 Feb 17
Episurf Medical AB (publ) Announces Dennis Stripe Not Stand for Re-Election as Chairman of the Board of Directors Feb 13
Episurf Medical AB (Publ) Receives Notice of Allowance from the United States Patent and Trademark Office Feb 03
Episurf Medical AB (publ) Receives FDA 510(k) clearance for Episealer® Patellofemoral System Dec 26
Consensus revenue estimates fall by 20% Nov 23
Third quarter 2022 earnings released Nov 18
Price target decreased to kr5.65 Nov 16 Episurf Medical AB (publ) to Report Fiscal Year 2023 Results on Feb 09, 2024
Episurf Medical Announces That the Episealer® Knee Technology and Clinical Results Nov 11
Episurf Medical AB (Publ) Appoints Nomination Committee Oct 15
We're Not Very Worried About Episurf Medical's (STO:EPIS B) Cash Burn Rate Sep 23
Episurf Medical AB (Publ) Provides Update on 510(K) Application to FDA for the Episealer Patellofemoral System Sep 21
Episurf Medical Announces New U.S. Patent Approval for Episurf Medical Aug 20
Episurf Medical AB (Publ) Announces New Patent Approval in Hong Kong for Episurf Medical Aug 18
Episurf Medical Announces Results from Study with Episealer® Knee Implant Accepted for Presentation at Swedish Orthopaedic Congress Aug 16
Consensus forecasts updated Jul 22
Episurf Medical AB (Publ) Announces New Patent Approval in Hong Kong Jul 21
Second quarter 2022 earnings released Jul 16
Episurf Medical AB (Publ) Announces First Surgery in India with the Knee Implant Episealer® Has Been Scheduled Jun 29
First quarter 2022 earnings: Revenues miss analyst expectations May 01
Price target decreased to kr5.65 Apr 27
Episurf Medical Provides Updates of 510(K) Application on Episealer Patellofemoral System Apr 25
New European Patent Approves for Episurf Medical Apr 20 Episurf Medical AB (Publ) Announces the Initiation of a Prospective Investigator-Initiated Study with 2 Years Follow-Up of 25 Episealer Talus Patients
First Indian Patent Approval for Episurf Medical Apr 06
Episurf Medical Receives Reimbursement Coverage for Episealer Talus in Belgium Feb 24
Episurf Medical AB’s Implants Receive National Regulatory Approval in Hong Kong Feb 19
Consensus revenue estimates fall by 34% Feb 18
Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind Feb 12
The European Patent Office Approves European Patent for Episurf Medical Feb 03
the European Patent Office EPO Announces Its Intention to Grant Another European Patent for Episurf Medical AB (publ) Jan 18
Episurf Medical Submits 510(K) Application for Episealer® Patellofemoral System Dec 31
Board Member recently bought kr798k worth of stock Dec 15
CEO & Acting Sales Director recently bought kr185k worth of stock Nov 25
Chief Financial Officer recently bought kr51k worth of stock Nov 03
Third quarter 2021 earnings released Oct 30
Episurf Medical (STO:EPIS B) Is In A Good Position To Deliver On Growth Plans Oct 30
Independent Director recently bought kr98k worth of stock Sep 23
Episurf Medical AB (Publ) Announces Results from Multicentre Study Sep 02
Independent Chairman of the Board recently bought kr59k worth of stock Aug 27
Episurf Medical Announces the Initiation of Prospective Investigator-Initiated European Multicentre Study with 5 Years' Follow-Up of 25 Episealer® Talus Patients Jul 24
Chief Financial Officer recently bought kr131k worth of stock Jul 20
Second quarter 2021 earnings released: kr0.08 loss per share (vs kr0.084 loss in 2Q 2020) Jul 18 Shareholder Returns EPIS B SE Medical Equipment SE Market 7D -2.7% -1.0% -0.5% 1Y -88.1% 0.1% 12.8%
See full shareholder returns
Return vs Market: EPIS B underperformed the Swedish Market which returned 12.8% over the past year.
Price Volatility Is EPIS B's price volatile compared to industry and market? EPIS B volatility EPIS B Average Weekly Movement 10.0% Medical Equipment Industry Average Movement 7.9% Market Average Movement 5.8% 10% most volatile stocks in SE Market 12.1% 10% least volatile stocks in SE Market 3.2%
Stable Share Price: EPIS B's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: EPIS B's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also provides Episealer Talus, a solution for the treatment of bone and cartilage defects in the talus bone of the ankle joint; Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning.
Show more Episurf Medical AB (publ) Fundamentals Summary How do Episurf Medical's earnings and revenue compare to its market cap? EPIS B fundamental statistics Market cap SEK 69.58m Earnings (TTM ) -SEK 76.00m Revenue (TTM ) SEK 20.60m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) EPIS B income statement (TTM ) Revenue SEK 20.60m Cost of Revenue SEK 9.90m Gross Profit SEK 10.70m Other Expenses SEK 86.70m Earnings -SEK 76.00m
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Mar 06, 2025
Earnings per share (EPS) -0.12 Gross Margin 51.94% Net Profit Margin -368.93% Debt/Equity Ratio 0%
How did EPIS B perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/21 02:32 End of Day Share Price 2025/02/21 00:00 Earnings 2024/12/31 Annual Earnings 2024/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources Episurf Medical AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Yilmaz Mahshid Pareto Securities Anders Hedlund Redeye John Westborg Redeye
